JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA631467
Type: ADME
Description: phase 1 oral half life at a dose 200 mg.
Bioactivity
Activity Types for Assay ALA631467
T1/2